comparemela.com

Alwin Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tencent co-leads China s SanegeneBio s extended Series A round

Besides its headquarters in Suzhou and Boston, Massachusetts, the firm also has a clinical operation centre in Shanghai.

United statesOriza holdingsShenzhen capital groupYuanbio ventureNorthern light venture capitalQiming venture partnersAlwin capitalInvestigational new drugGreater china

Chinese biotech firm Genecast refiles for Hong Kong IPO

The listing comes at a time when profits remains one of the major concerns among investors.

Hong kongGenecast groupMeagher flomChina structural reform fundCo win venturesAlwin capitalLoyal valley capitalMatrix partners chinaHong kong exchanges

China s genome sequencing firm Qitan Tech bags $100m in Series C round

Previously, Qitan raised 400 million yuan ($63 million) in a Series B round.

Haoyue wechatInnovation fundQitan techBiotrack capitalHuagai capitalRiverhead capitalBaidu venturesAlwin capitalYinxinggu capitalGaorong capital

China s Alwin Capital closes second dual-currency fund this month at over $300m

It had closed a separate dual-currency fund earlier this month worth $281m for the life sciences industry.

Shi huijingAbogen biosciencesSun yanaNeukio biotherapeuticsChina international capital corporationAlwin capital

China s Alwin Capital closes new dual-currency fund at $281m to invest in life sciences

The firm is focused on R&D, medical devices, molecular diagnostics, gene editing, and more.

Hong kongShi huijingAbogen biosciencesSun yanaAdlai nortyeChina international capital corporationAsset management association of chinaAlwin capitalBeijing headquartered alwin capitalAsset management associationMatrix partners chinaHuigene therapeutics

vimarsana © 2020. All Rights Reserved.